Research & Development

The long-term vision and strategic focus of Upsher-Smith is to deliver therapies and solutions that measurably improve individuals’ lives. By focusing on the following therapeutic areas, we are able to bring innovative products to clinicians, pharmacists, and patients.

While our focus has always been on improving lives, we are now directing significant efforts toward patients living with central nervous system (CNS) disorders such as seizure disorder, also known as epilepsy. At Upsher-Smith, we are committed to making a difference in seizure disorder management.
Proximagen Limited is the drug discovery and development subsidiary of Upsher-Smith. Proximagen currently focuses on diseases of the CNS, as well as pain and inflammation.